Showing results (181-190 of 342) with videos related to

Sort By:
Pageof 35
Internal Medicine Journal|August 2, 2023
Diagnosis and management of endothelial disorders following haematopoietic stem cell transplantationAshley McEwan, Matthew Greenwood, Christopher Ward, et al.
Blood|February 24, 2023
Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysisGerard Socié, Dietger Niederwieser, Nikolas von Bubnoff, et al.
American Journal of Medical Genetics|July 13, 2002
C7 complement deficiency in an Israeli Arab villageDoron Behar, Menachem Schlesinger, David Halle, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2014
Screening with spirometry is a useful predictor of later development of noninfectious pulmonary syndromes in patients undergoing allogeneic stem cell transplantationPhilip A Thompson, Andrew Lim, Yvonne Panek-Hudson, et al.
International Journal of Molecular Sciences|August 29, 2024
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow FunctionJeff Szer, Jens Panse, Austin Kulasekararaj, et al.
Blood Cells, Molecules & Diseases|August 6, 2010
Preimplantation genetic diagnosis (PGD) for a treatable disorder: Gaucher disease type 1 as a modelGheona Altarescu, Paul Renbaum, Talia Eldar-Geva, et al.
Blood|July 5, 2007
Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacementDeborah Elstein, Altoon Dweck, Drorit Attias, et al.
International Journal of Molecular Sciences|June 26, 2019
Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher DiseaseNoa Hurvitz, Tama Dinur, Michal Becker-Cohen, et al.
Transplantation|April 16, 2004
Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantationCharles Mullighan, Sue Heatley, Kathleen Doherty, et al.
American Journal of Hematology|April 23, 2016
Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imigluceraseGregory M Pastores, Suma P Shankar, Milan Petakov, et al.
Pageof 35